Clinical Trial Update: Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing imatinib to interferon-α plus cytarabine in newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia. Results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Gleevec (Imatinib)
• Interferon alfa-2b (Intron A) (interferon alfa-2b)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myelogenous Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2013-10-14